STAT Plus: Merck’s Roger Perlmutter joins board of AI drug discovery startup Insitro

Roger Perlmutter, the head of research and development at Merck, is joining the board of Insitro, a firm focused on using artificial intelligence to discover drugs.

Insitro, backed with $243 million in venture capital from firms including Casdin Capital and ARCH Venture Partners, was founded by Daphne Koller, known for co-founding Coursera, the online learning firm, and working at Calico, a drug discovery arm of Alphabet. The company has a research partnership with Gilead Sciences.

Continue to STAT Plus to read the full story…